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	 Free	 radicals	 are	 constantly	 formed	 in	 human	 system	 either	 as	 accidental	 products	 during
metabolism	 or	 deliberately	 during	 the	 process	 of	 phagocytosis	 or	 due	 to	 environmental
pollutants,	 ionizing	 radiations,	 ozone,	heavy	metal	poisoning,	 etc.	 It	 is	 found	 from	 literature
survey	 that	 chalcones	 (α,β‐unsaturated	 carbonyl	 derivatives)	 exhibit	 great	 antioxidant
activity.	 Hence,	 the	 synthesis	 of	 some	 new	 chalcone	 derivatives	 was	 undertaken	 and	were
synthesized	by	 two	methods	namely,	 conventional	 and	microwave	 irradiation	methods.	The
synthesized	 chalcone	 derivatives	were	 tested	 for	 their	 in	 vitro	antioxidant	 activity	 by	 using
NBT‐superoxide	 free‐radical	 scavenging	 activity	 and	 DPPH	 radical	 scavenging	 activity.	 The
potency	 of	 the	 chalcone	 derivatives	 was	 estimated	 by	 IC50	 values	 and	 they	 have	 shown
promising	 antioxidant	 activity.	 Among	 all	 the	 chalcones	 synthesized,	 derivative	3e	 showed
maximum	 superoxide	 inhibition	 as	 per	 NBT	 method	 and	 all	 the	 derivatives	 have	 shown
different	 percentage	 inhibitions	 at	 different	 concentrations	 as	 per	 	 DPPH	 method.	 The
compounds	were	characterized	by	1H	NMR	and	IR	spectral	analysis.	
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1.	Introduction	
	
Chalcones	are	1,3‐diphenyl‐2‐propene‐1‐one	[1,2],	in	which	
two	 aromatic	 rings	 are	 linked	 by	 a	 three	 carbon	 α,β‐
unsaturated	 carbonyl	 system.	 These	 are	 abundant	 in	 edible	
plants	 and	 are	 considered	 to	 be	 the	 precursors	 of	 flavonoids	
and	 isoflavonoids.	 Chalcones	 are	 synthesized	 by	 Claisen‐
Schmidt	condensation,	which	involves	cross	aldol	condensation	
of	appropriate	aldehydes	and	ketones	by	base	catalyzed	or	acid	
catalyzed	 followed	 by	 dehydration.	 Chalcone	 is	 a	 common	
natural	pigment	 and	one	of	 the	 important	 intermediate	 in	 the	
biosynthesis	 of	 flavonoids	 [3].	 Synthetic	 and	 naturally	
occurring	 chalcones	 have	 been	 extensively	 studied	 and	
developed	as	one	of	the	pharmaceutically	important	molecules	
[4,5].	 Chalcone	 derivatives	 are	 screened	 for	 their	 anti‐
inflammatory	 activity	 [6],	 chemopreventive	 activity	 [7],	
cardiovascular	 disease	 [8],	 anticancer	 activity	 [9],	 cytotoxic	
activity	[10],	antiprolifirative	activity	[11],	antimalarial	activity	
[12],	antiviral	activity	[13],	anti‐HIV	activity	[14].	Therefore,	in	
the	 present	 investigation	 it	 was	 considered	 worthwhile	 to	
synthesize	some	new	chalcone	derivatives	by	conventional	and	
microwave	 irradiation	methods	 and	 comparison	between	 two	
methods.	
Microwave‐induced	organic	reaction	enhancement	(MORE)	
chemistry	 is	 gaining	 popularity	 as	 a	 non‐conventional	
technique	 for	 rapid	 organic	 synthesis.	 Important	 features	 of	
this	 technique	are	easy	access	 to	very	high	 temperature,	good	
control	over	energy	input	in	a	reaction,	higher	yields	and	rapid	
synthesis	 of	 organic	 compounds.	 The	 effect	 of	 microwave	
irradiation	is	due	to	the	combination	of	both	thermal	and	non‐
thermal	effects.	It	is	characterized	by	spectacular	accelerations	
produced	 in	 many	 reactions,	 which	 cannot	 be	 observed	 in	
classical	heating	[15‐17].	
The	 synthesized	 compounds	 were	 purified	 by	
recrystallization	 and	 chromatography.	 The	 compounds	 were	
characterized	by	1H	NMR	and	IR	analysis.	The	compounds	were	
tested	 for	 their	 potential	 antioxidant	 activities	 by	 standard	
methods.	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
All	 the	melting	points	 of	 the	 derivatives	were	 determined	
by	digital	melting	point	apparatus	(SMP	10).	The	NMR	spectra	
were	 recorded	 on	 a	 BRUKER	 DRX	 400	 spectrometer	 at	 400	
MHz	 (1H).	 IR	 spectra	 were	 recorded	 using	 an	 ALPHA	 FT‐IR	
spectrometer	 (Bruker).	 High	 resolution	 mass	 spectra	 were	
obtained	 on	 Agilent	 6100	 Series	 Single	 Quadrupole	 LC/MS.	
Precoated	 TLC	 plates	 from	 Merck	 were	 used.	 Commercial	
compounds	were	purchased	from	Aldrich	Chemical	Co.	
	
2.2.	General	procedure	for	the	synthesis	of	chalcones	(3a‐3g)	
by	Claisen‐Schmidt	condensation	
	
2.2.1.	Conventional	method	
	
Claisen‐Schmidt	 condensation	 [18‐23]	 of	 chalcones	 by	
conventional	method	involves	addition	of	equimolar	quantities	
(0.001	 mol)	 of	 2‐acetyl‐5‐chloro‐thiophene	 and	 respective	
aldehydes	(0.001	mol)	[5].		
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R3 = H (3a), H (3b), H (3c), OCH3 (3d), H (3e). 
	
Scheme	1
	
	
The	reaction	mixture	was	mixed	and	dissolved	in	minimum	
amount	 (3	 mL)	 of	 alcohol.	 To	 this,	 aqueous	 potassium	
hydroxide	 solution	 (0.003	mol)	 was	 slowly	 added	 and	mixed	
occasionally	for	24	hrs,	at	room	temperature.	Completion	of	the	
reaction	 was	 identified	 by	 observing	 on	 precoated	 thin	 layer	
chromatography	(TLC)	plates.	After	completion	of	the	reaction,	
the	 reaction	 mixture	 was	 poured	 into	 crushed	 ice,	 acidified	
with	diluted	HCl	(if	necessary).	The	separated	solid	was	filtered	
and	 dried.	 It	 was	 purified	 by	 recrystallization	 or	 by	 column	
chromatography	performed	on	silica	gel	(100‐200	Mesh),	using	
ethylacetate	and	hexane	mixture	as	mobile	phase	 (Scheme	1),	
(Tables	1	and	2)	[5].	
	
2.2.2.	Microwave	irradiation	method	(MWI)	
	
Equimolar	 quantities	 (0.001	 mol)	 of	 acetyl	 heterocyclic	
compounds	and	respective	aldehydes	(0.001	mol)	were	mixed	
and	 dissolved	 in	 minimum	 amount	 (3	 mL)	 of	 alcohol	 [5].	 To	
this,	 aqueous	 potassium	 hydroxide	 solution	 (0.003	 mol)	 was	
added	 slowly	 and	 mixed.	 The	 entire	 reaction	 mixture	 was	
microwave	 irradiated	 in	 Catalyst	 Scientific	 Microwave	 Oven,	
Model:	 CATA	 2R,	 Range:	 140‐700W,	 Make:	 Catalyst	 System,	
Pune,	India,	for	about	2‐6	minutes	at	180	watts	[5].	
1‐(5‐chlorothiophen‐2‐yl)‐3‐[4‐(dimethyl	 amino)	 phenyl]	
prop‐2‐en‐1‐one	 (3a):	 Conventional	 yield:	 54%.	 Microwave	
yield:	 62%.	 M.p.:	 128‐130	 oC.	 FT‐IR	 (KBr,	 νmax,	 cm‐1):	 1625	
(C=O),	1551	 (HC=CH),	1317	(C‐N‐C),	772	(C‐S).	 1H	NMR	 	 (400	
MHz,	CDCl3,	,	ppm):	3.05	(6H,	s,	C‐4''‐N(CH3)2),	6.77	(2H,	d,	J	=	
9.6	Hz,	C‐3''	and	5''‐H),	6.98	(1H,	d,	J	=	4	Hz,	C‐4'‐H),	7.16	(1H,	d,	
J	 =	16.2	Hz,	CO‐CH=),	7.52	 (2H,	d,	 J	 =	9.2	Hz,	 	C‐2''	 and	6''‐H),	
7.61	(1H,	d,	 J	=	4	Hz,	C‐3'‐H),	7.84	(1H,	d,	 J	=	16	Hz,	Ar‐C‐H=).	
Anal.	calcd.	for	C15H14ClNOS:	C,	61.73;	H,	4.62;	S,	10.92.	Found:	
C,	61.75;	H,	4.64;	S,	10.89%.	
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Table	1.	Comparative	reaction	time	and	percentage	yield	of	chalcone	derivatives	by	conventional	and	microwave	irradiation	methods.	
Compound	no	 Molecular	weight	(g)	
Reaction	time Yield		
Conventional	(hr) MWI	(min) Conventional	(%)	 MWI	(%)
3a	 291.7	 24 4.5 54 62
3b	 278.7	 24 2.5 54 66
3c	 308.7	 24 2.5 52 61
3d	 338.8	 24	 2.5	 55	 67	
3e	 292.7	 24	 3.0	 58	 67	
3f	 237.7	 24 3.5 48 62
3g	 287.7	 24	 2.5	 51	 60	
	
Table	2.	Rf		values,	melting	point	(M.p.)	and	elemental	analysis	data	of	chalcone	derivatives.	
Compound	no	 Rf	value	 M.p.,	oC	
Elemental	analysis,	%
Calculated	 Found	
3a	 0.58	 128	±	2	 C:	61.73
H:	4.62	
S:	10.92	
C:	61.75	
H:4.64	
S:10.89	
3b	 0.64	 118	±	2		 C:	60.24	
H:	3.91	
S:	11.48	
C:	60.21	
H:	3.93	
S:	11.45	
3c	 0.57	 130	±	2		 C:	58.36	
H:	4.07	
S:	10.3	
C:	58.38	
H:	4.1	
S:	10.27	
3d	 0.52	 110	±	2 C:	56.8
H:	4.3	
S:	9.4	
C:	56.78	
H:	4.33	
S:	9.43	
3e	 0.61	 134	±	2	 C:	61.4
H:	4.28	
S:	10.9	
C:	61.37	
H:	4.3	
S:	10.87	
3f	 0.54	 162	±	2		 C:	55.53	
H:	3.18	
N:	5.86	
C:	55.51	
H:	3.21	
S:	5.84	
3g	 0.46	 158	±	2		 C:	62.56	
H:	3.41	
N:	4.86	
C:	62.53	
H:	3.38	
N:	4.89	
	
	
1‐(5‐chlorothiophen‐2‐yl)‐3‐(4‐methoxyphenyl)	 prop‐2‐en‐1‐
one	(3b):	Conventional	yield:	54%.	Microwave	yield:	66%.	M.p.:	
118‐120	oC.	FT‐IR	(KBr,	νmax,	cm‐1):	1643	(C=O),	1587	(HC=CH),	
1228	(C‐O‐C),	800	(C‐Cl),	722(C‐S).	1H	NMR	(400	MHz,	CDCl3,	,	
ppm):	3.86	(3H,	s,	C‐4''‐OCH3),	6.88	(2H,	d,	J	=	8.4	Hz,	C‐3''	and	
5''‐H),	7.01	(1H,	d,	J	=	4	Hz,	C‐4'‐H),	7.18	(1H,	d,	J	=	15.6	Hz,	CO‐
CH=),	7.60	(2H,	d,	J	=	8.4	Hz,		C‐2''	and	6''‐H),	7.62	(1H,	d,	J	=	4.4	
Hz,	C‐3'‐H),	7.83	 (1H,	d,	 J	 =	 15.2	Hz,	Ar‐C‐H=).	Anal.	 calcd.	 for	
C14H11ClO2S	 :	 C,	 60.24;	 H,	 3.91;	 S,	 11.48.	 Found:	 C,	 60.21;	 H,	
3.93;	S,	11.45%.	
1‐(5‐chlorothiophen‐2‐yl)‐3‐(3,4‐dimethoxyphenyl)	 prop‐2‐
en‐1‐one	(3c):	Conventional	yield:	52%.	Microwave	yield:	61%.	
M.p.:	 130‐132	 oC.	 FT‐IR	 (KBr,	 νmax,	 cm‐1):	 3084	 (C‐H),	 1644	
(C=O),	 1586	 (HC=CH),	 1259	 (C‐O‐C),	 795	 (C‐Cl),	 714(C‐S).	 1H	
NMR	(400	MHz,	CDCl3,	,	 	ppm):	3.93	 (3H,	s,	C‐3''‐OCH3),	3.95	
(3H,	s,	C‐4''‐OCH3),	6.89	(1H,	d,	J	=	8.2	Hz,	C‐5''‐H),	6.99	(1H,	d,	J	
=	4	Hz,	C‐4'‐H),	7.16	(1H,	d,	J	=	I5.2	Hz,	CO‐CH=),	7.22‐7.26	(2H,	
d,	 J	 =	9.6	Hz,	C‐2''and	6''‐H),	 	 7.64	 (1H,	d,	 J	 =	3.6	Hz,	C‐	3'‐H),	
7.81	(1H,	d,	J	=	16.2	Hz,	Ar‐C‐H=).	Anal.	calcd.	for	C15H13ClO3S:	C,	
58.36;	H,	4.07;	S,	10.3.	Found:	C,	58.38;	H,	4.1;	S,	10.27%.	
1‐(5‐chlorothiophen‐2‐yl)‐3‐(3,4,5‐trimethoxyphenyl)	 prop‐
2‐en‐1‐one	 (3d):	 Conventional	 yield:	 55%.	 Microwave	 yield:	
67%.	 	 M.p.:	 110‐112	 oC.	 FT‐IR	 (KBr,	 νmax,	 cm‐1):	 3095	 (C‐H),	
1646	(C=O),	1585	(HC=CH),	1217	(C‐O‐C),	819	(C‐Cl),	769(C‐S).	
1H	NMR	(400	MHz,	CDCl3,	,	ppm):	1.57	(3H,	s,	C‐4''‐OCH3),	3.91	
(6H,	d,	J	=	8	Hz,	C‐3''	and	5''‐OCH3),	6.84	(2H,	s,	C‐2''	and	6''‐H),	
7.01	 (1H,	 d,	 J	 =	 4.2	Hz,	 C‐	 4'‐H),7.22	 (1H,	 d,	 	 J	 =	 10.6	Hz,	 CO‐
CH=),	7.64	(1H,	d,	J	=	4	Hz,	C‐	3'‐H),	7.79	(1H,	d,	J	=	9.4	Hz,	Ar‐C‐
H=).	Anal.	calcd.	for	C16H15ClO4S:	C,	56.8;	H,	4.3;	S,	9.4.	Found:	C,	
56.78;	H,	4.33;	S,	9.43%.	
1‐(5‐chlorothiophen‐2‐yl)‐3‐(4‐ethoxyphenyl)	 prop‐2‐en‐1‐
one	 (3e):	 Conventional	 yield:	 58%.	 Microwave	 yield:	 67%.		
M.p.:	 134‐136	 oC.	 FT‐IR	 (KBr,	 νmax,	 cm‐1):	 1643	 (C=O),	 1585	
(HC=CH),	1220	(C‐O‐C),	772	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	,	
ppm):	 1.40	 (3H,	 t,	 C‐4''‐OCH3),	 4.10	 (2H,	 dd,	 C‐4''‐OCH2),	 6.93	
(2H,	d,	J	=	9.6Hz,	C‐3''	and	5''‐H),		6.98	(1H,	d,	J	=	3.8	Hz,	C‐4'‐H),	
7.21	(1H,	d,	 J	=	15.8	Hz,	CO‐CH=),	7.56	(2H,	d,	J	=	10	Hz,	C‐	2''	
and	6''‐H),	7.62	(1H,	d,	J	=	4	Hz,	C‐3'‐H),	7.82	(1H,	d,	J	=	16	Hz,	
Ar‐C‐H=).	Anal.	calcd.	 for	C15H13ClO2S:	C,	61.4;	H,	4.28;	S,	10.9.	
Found:	C,	61.37;	H,	4.3;	S,	10.87%.	
1‐(5‐chlorothiophen‐2‐yl)‐3‐(1H‐pyrrol‐2‐yl)	 prop‐2‐en‐1‐
one	(3f):	Conventional	yield:	48%.	Microwave	yield:	62%.	M.p.:	
162‐164	 oC.	 FT‐IR	 (KBr,	 νmax,	 cm‐1):	 3242	 (N‐H),	 1635	 (C=O),	
1545	 (HC=CH),	 1284	 (C‐N‐C),	 771	 (C‐S),	 731	 (C‐Cl).	 1H	 NMR	
(400	MHz,	CDCl3,	,	ppm):		4.10	(1H,	m,	N‐H),	6.20	(2H,	d,	J	=	8	
Hz,	C‐3''	and	5''‐H),	6.91	(1H,	d,	J	=	8	Hz,	C‐4''‐H),	7.21	(1H,	d,	J	=	
4	Hz,	C‐4'‐H),	7.32	(1H,	d,	J	=	15.6	Hz,			CO‐CH=),	7.61	(1H,	d,	J	=	
4.2	Hz,	C‐	3'‐H),	7.84	(1H,	d,	J	=	16	Hz,	Ar‐C‐H=).	Anal.	calcd.	for	
C11H8ClNOS:	C,	55.53;	H,	3.18;	N,	5.86.	Found:	C,	55.51;	H,	3.21;	
N,	5.84%.	
1‐(5‐chlorothiophen‐2‐yl)‐3‐(1H‐indol‐3‐yl)	 prop‐2‐en‐1‐one	
(3g):	 Conventional	 yield:	 51%.	 Microwave	 yield:	 60%.	 M.p.:	
158‐160	 oC.	 FT‐IR	 (KBr,	 νmax,	 cm‐1):	 3212	 (N‐H),	 1633	 (C=O),	
1519	 (HC=CH),	 1220	 (C‐N‐C),	 770(C‐S).	 1H	 NMR	 (400	 MHz,	
CDCl3,	,	ppm):	7.20	(1H,	d,	J	=	4	Hz,	C‐4'‐H),	7.22‐7.27	(4H,	m,	C‐
4'',	5'',	6''and	7''‐H),	7.53	(1H,	d,	J	=	15.2	Hz,	CO‐CH=),	8.15	(1H,	
d,	J	=	4.2	Hz,	C‐3'‐H),	8.28	(1H,	d,	J	=	16	Hz,	Ar‐C‐H=),	9.95	(1H,	
s,	C‐	3''‐H),	12.13	(1H,	s,	N‐H).	Anal.	 calcd.	 for	C15H10ClNOS:	C,	
62.56;	H,	3.41;	N,	4.86.	Found:	C,	62.53;	H,	3.38;	N,	4.89%.	
	
2.3.	Pharmacological	activity	
	
2.3.1.	Antioxidant	activity	
	
Free	radicals	are	constantly	formed	in	human	system	either	
as	 accidental	 products	 during	 metabolism	 or	 deliberately	
during	 the	 process	 of	 phagocytosis	 or	 due	 to	 environmental	
pollutants,	 ionizing	 radiations,	 ozone,	 heavy	 metal	 poisoning,	
cigarette	 smoking	 and	 chronic	 alcohol	 intake.	 Free	 radicals	
being	highly	reactive	can	oxidize	biomolecules	leading	to	tissue	
injury	 and	 cell	 death.	 In	 the	 present	 study,	 two	 in	 vitro	
antioxidant	 models	 1,1‐diphenyl‐2‐picrylhydrazyl	 radical	
(DPPH•)	 scavenging	 activity	 (as	 it	 is	 a	 model	 for	 lipophilic	
radicals	 which	 initiate	 lipid	 peroxidation)	 and	 nitro	 blue	
tetrazolium	 (NBT)‐Riboflavin	 photo	 reduction	 method	 were	
used.	The	 IC50	values	of	chalcones,	 tested	 for	 their	antioxidant	
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activity	were	also	calculated.	Solvent	used	in	both	the	tests	for	
compounds	was	DMSO	(Dimethylsulfoxide).		
	
2.3.2.	 Procedure	 for	 superoxide	 free‐radical	 scavenging	
activity	
	
2.3.2.1.	NBT‐Riboflavin	photo	reduction	method	
	
Superoxide	 scavenging	 activity	 of	 the	 compounds	 was	
determined	 by	 McCord	 and	 Fridovich	 method	 [24],	 which	
depends	on	 light	 induced	 superoxide	 generation	by	 riboflavin	
and	 corresponding	 reduction	 of	 NBT	 [25‐27].	 The	 assay	
mixture	 contained	 EDTA	 (Ethylenediamine	 tetra‐acetic	 acid)	
solution	 (6.6	mM)	 containing	NaCN	 (3	 µg),	 riboflavin	 (2	 µM),	
NBT	(50	µM),	test	substances	and	phosphate	buffer	(67	mM,	pH	
=	 7.8)	 in	 a	 final	 volume	 of	 3	mL.	The	 absorbances	 at	 560	nm	
were	measured,	 before	 and	 15	minutes	 after	 illumination.	 All	
tests	 were	 run	 in	 triplicate	 and	 mean	 values	 were	 used	 to	
calculate	 percentage	 scavenging	 ability	 and	 IC50	 values	 were	
calculated	 (using	 linear	 regression	 analysis).	 The	 inhibitory	
effects	of	samples	on	the	generation	of	superoxide	anions	were	
estimated	by	the	equation	(1).	
	
Percentage	Inhibition	=	[(A0‐	A1)	x	100]	/	A0	 	 (1)	
	
where	A0	is	the	absorbance	with	no	addition	of	sample	A1	is	the	
absorbance	with	addition	of	sample.	
	
2.3.2.2.	DPPH	free‐radical	scavenging	activity	
	
DPPH	 (1,1‐diphenyl‐2‐picrylhydrazyl)	 radical	 scavenging	
activity	 was	 measured	 by	 the	 method	 of	 Lamaison	 [28].	 The	
reaction	mixture	contained	1.5	x	10‐7	M	methanolic	solution	of	
DPPH	 and	 various	 concentrations	 of	 the	 test	 substances	 and	
were	kept	 in	darkness	for	50	minutes.	Optical	density	(OD)	of	
samples	 was	 measured	 at	 517	 nm	 against	 a	 blank,	 and	 IC50	
values	 were	 calculated	 (using	 linear	 regression	 analysis)	 by	
plotting	a	graph,	taking	concentration	on	X‐axis	and	percentage	
inhibition	on	Y‐axis.	The	IC50	values	were	obtained	by	drawing	
a	line	from	Y‐axis	and	aligning	with	the	concentration	on	X‐axis	
at	50%	of	percentage	inhibition.	
	
3.	Results	and	discussion	
	
The	 in	 vitro	 antioxidant	 activity	 and	 scavenging	 effects	 of	
the	seven	chalcones	were	evaluated	by	using	different	reactive	
species	 assay	 containing	 NBT‐superoxide	 free‐radical	
scavenging	 activity	 and	DPPH	 free‐radical	 scavenging	 activity.	
The	potency	of	the	chalcone	derivatives	was	estimated	by	IC50	
values.	
	
3.1.	NBT‐superoxide	radical	scavenging	activity	
	
All	 the	 chalcones	 (3a‐3g)	 were	 found	 to	 scavenge	 the	
superoxides	generated	by	photo‐reduction	of	riboflavin.	Among	
them,	 compounds	 3e	 showed	 maximum	 inhibition	 of	
superoxide	radicals	at	concentrations	of	25,	50	and	100	µg/mL	
and	 also	 the	 IC50	 values	 were	 found	 to	 be	 the	 best	 of	 all	 the	
synthesized	 derivatives.	 The	 remaining	 compounds	 (Table	 3),	
exhibited	less	activity	when	compared	to	the	above	compounds	
at	similar	concentration	levels.	
Gallic	 acid,	 the	 known	 antioxidant	 was	 employed	 in	 the	
study	for	comparing	the	results,	at	concentrations	of	0.25,	0.50	
and	0.75	µg/mL;	compound	3e	appeared	to	be	the	best	among	
all	 the	 tested	 compounds.	 Few	 of	 the	 chalcone	 derivatives	
showed	 good	percentage	 inhibition	 but	 their	 IC50	 values	were	
more.	 Hence	 they	 were	 less	 potent	 among	 the	 tested	
compounds	with	respect	to	IC50	values.		
	
	
Table	 3.	 Percentage	 inhibition	 of	 superoxide	 radical	 using	 NBT‐riboflavin	
photo	reduction	method	(Compounds	3a‐3g).	
Compounds	
Quantity	(µg/mL)		
25	µg/mL 50	µg/mL	 100	µg/mL	 IC50,	µg/mL
3a 30.18 41.55 64.40	 >100
3b 16.04 18.45 20.23	 >100
3c 28.07 32.51 34.68	 90.97
3d 23.58 33.33 53.69	 >100
3e 17.03 11.85 4.36	 20.33
3f 30.18 40.93 54.66	 76.25
3g	 37.85	 43.69	 59.74	 83.71	
Gallic	acid	 31.21	
0.25	µg/mL	
40.00	
0.50	µg/mL	
59.83	
0.75	µg/mL	
0.61	
	
	
3.2.	DPPH‐radical	scavenging	activity	
	
The	free	radical	scavenging	activity	of	all	the	chalcones	(3a‐
3g)	were	evaluated	 through	 their	ability	 to	quench	 the	DPPH•	
using	 ascorbic	 acid	 as	 reference.	 	 All	 the	 synthesized	
derivatives	 have	 shown	 different	 percentage	 inhibitions	 at	
concentrations	 of	 25,	 50	 and	 100	 µg/mL	 and	 also	 their	 IC50	
values	 were	 also	 calculated	 (Table	 4).	 The	 percentage	
inhibitions	of	ascorbic	acid	were	found	at	concentrations	of	1.0,	
2.5,	5.0	µg/mL.	
	
Table	 4.	 Percentage	 inhibition	 of	 free	 radicals	 using	 DPPH	 method	
(Compounds	3a‐3g).	
Compounds	
Quantity	(µg/mL)		
25	µg/mL	 50	µg/mL	 100	µg/mL	 IC50,	µg/mL	
3a 5.92 9.30 9.14	 >100
3b 9.51 10.78 18.68	 >100
3c	 3.54	 8.25	 16.54	 >100	
3d	 18.76	 25.32	 34.62	 >100	
3e	 0.90	 1.17	 11.16	 >100	
3f	 5.55	 9.30	 10.15	 >100	
3g 12.69 14.02 28.37	 >100
Ascorbic	
acid	
16.13
1.0	µg/mL	
38.11
2.5	µg/mL	
62.34	
5.0	µg/mL	
3.81
	
4.	Conclusion	
	
The	 synthesis	 of	 chalcones	 by	 conventional	 method	 and	
microwave	 irradiation	 method	 showed	 that	 MWI	 is	 a	
preferable	method	because	of	 rapid	 synthesis	 and	also	higher	
yield	of	products.	All	the	synthesized	compounds	were	purified	
by	 recrystallization	 or	 by	 column	 chromatography.	 The	
characterization	of	 compounds	was	established	by	single	 spot	
TLC,	 melting	 point	 and	 by	 spectral	 analysis	 involving	 IR,	 1H	
NMR,	 Mass	 and	 elemental	 analysis.	 Since	 chalcones	 were	
widely	 reported	 to	 possess	 promising	 antioxidant	 activity.	 All	
the	chalcone	derivatives	(3a‐3g)	were	evaluated	for	the	above	
mentioned	 activity.	 It	 was	 found	 that	 3e	 showed	 maximum	
inhibition	of	superoxide	radicals,	as	per	NBT	method	and	all	the	
derivatives	 have	 shown	 different	 percentage	 inhibitions	 at	
different	concentrations	as	per	DPPH	method.	
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